3,5-Dimethyl-2-cyclohexen-1-one

Catalog No.: 
ACKEBJ964
CAS No.: 
1123-09-7
Molecular Formula: 
C8H12O
Molecular Weight: 
124.18
3,5-Dimethyl-2-cyclohexen-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$112.00In stockInquiry
25g95%$450.00InquiryInquiry
100g95%$1452.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,5-Dimethyl-2-cyclohexen-1-one
IUPAC Name3,5-dimethylcyclohex-2-en-1-one
MDL No.MFCD00001583
Molecular FormulaC8H12O
Molecular Weight124.18
SMILESO=C1C=C(C)CC(C)C1
InChI KeyNOQKKFBBAODEHN-UHFFFAOYSA-N
Synonym2-Cyclohexen-1-one, 3,5-dimethyl- | EINECS 214-369-2 | NSC10113 | NSC-10113 | CS-0218032 | AI3-21772 | EN300-98240 | AKOS015917649 | A802550 | E78362 | DTXSID20870848 | FT-0658302 | 3,5-Dimethyl-2-cyclohexen-1-one, 98% | 3,5-dimethylcyclohexenone | MFCD00
CAS No.1123-09-7
PubChem CID14291

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACKEBJ964 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQLVD372 route compound structure diagram
    ACQLVD37212012-95-2In Stock
  4. Then
  5. ACKEBJ964 route product structure diagram
    ACKEBJ9641123-09-7In Stock
Inquiry

2. ACKEBJ964 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKEBJ964 route product structure diagram
    ACKEBJ9641123-09-7In Stock
Inquiry

3. ACKEBJ964 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKEBJ964 route product structure diagram
    ACKEBJ9641123-09-7In Stock
Inquiry

Comments (0)